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INTRODUCTION
Lipids found in human plasma are transported as components of 
lipoproteins. In this form, lipids such as triglycerides, cholesterol and 
cholesterol esters, and phospholipids are associated with a number of 
proteins known as apolipoproteins. These lipoproteins are composed of a 
nutral lipid core surrounded by a layer of cholesterol, phospholipid, and 
apolipoprotein, oriented so that the polar head groups and amino acids 
are external. The various lipoproteins are classified according to 
ultracentrifugal densities, and consist of Chylomicrons, Very Low Density 
Lipoproteins (VLDL), Low Density Lipoproteins (LDL), and High Density 
Lipoproteins (HDL).
There are dynamic interactions between all of these lipoproteins. 
Chylomicrons, the least dense of all the lipoproteins, are formed in the 
intestine, and function as a transport system for dietary triglycerides. 
VLDL are synthesized in the liver and small intestine and carry 
endogenous triglycerides before degrading into LDL. These LDL contain 
approximately 60% of total serum cholesterol for the most part in the 
form of a cholesterol ester rich core. A high level of circulating plasma 
LDL concentration has been associated with an increased risk of coronary 
heart disease^.
While much research has been done on LDL, growing evidence of 
HDL's role in the prevention of atherosclerotic disease has increased 
interest into the study of this lipoprotein^. Nascent High Density
1
2Lipoproteins are formed in several ways in vivo. They are formed, in 
part, in the circulation from surface components of Chylomicrons and 
VLDL, as well as in the liver and intestines. These nascent HDLs are less 
than 200 angstroms in diameter and approximately 45 angstroms thick. 
In some manner not yet fully understood, these nascent HDL particles are 
able to acquire cholesterol from cellular membranes/ This cholesterol is 
then acted upon by the enzyme Lecithin Cholesterol Acyl Transferase 
(LCAT). LCAT acts by transforming the cholesterol into cholesterol 
esters, which are then incorporated into the lipid core. This fills the core 
of the nascent particle, transforming it into a mature, spherical HDL 
particle. This uptake and conversion of cholesterol occurs so rapidly that, 
in normal plasma, only mature HDL may be detected. This mature 
particle continues to circulate, and transfers these cholesterol esters to 
LDL and VLDL which transport them to the liver, adrenal cortex, and 
gonads, where they may be metabolized or excreted1 /
The mechanism by which nascent High Density Lipoproteins are 
formed is, as yet. not fully understood. Discoidal, HDL-like micelles have 
proven to be an accurate model of nascent HDL particles and have been 
used in many experiments. Apolipoproteins A-1 and C's may be isolated 
from human HDL by delipidation and separated by gel-filtration by 
passage through two Sephacryl 200 columns (90 x 2.5 cm each) in series. 
Apolipoprotein C's may also be prepared in a slightly different manner 
using plasma VLDL as a source as cited by Jonas^*7 . In the following 
experiments, discoidal, micellar complexes will be used in a study of 
factors which may have an impact upon HDL production in viva Two
3series of io vitro experiments were performed in this study.
The first series of experiments was a study of product formation. A 
series of vesicle preparations were made up in order to illustrate what 
effect apolipoprotein C s might have when added to an Apo A-1 /  lipid 
vesicle system. Two controls were used in this experiment, a system into 
which only Apo A-1 was added and a system containing only Apo C's. In 
addition, three other systems were set up containing both apolipoproteins 
in.varying orders of addition. By comparison with the standards, the 
effects of the Apo C's upon the system may be seen. Lipid vesicles in this 
series of experiments were prepared by utilizing an ultrasonication 
technique similar to that used by Huang*
The second series of experiment used a different approach to the 
problem. In this series, rather than be concerned with a study of 
products, the main focus was a study of the kinetics of particle formation 
in the presence of various lipids modifying the lipid bilayer. Similar 
work has been done by Pownall et */.'™  and others * * This series 
of experiments will expand upon this work by studying the effects of 
palmitic acid, myristic acid, di-myristoyl phosphatidyl ethanolamine 
(DMPE). di-palmitoyl phosphatidyl ethanolamine (DPPE), di-palmitoyl 
phosphatidyl serine (DPPS), and cholesterol upon the spontaneous 
degradation by Apo A-l of multi-lamellar vesicles (MLV's) of 
di-myristoyl phosphatidyl choline (DMPC) into discoidal particles as noted 
by Jonas^.
It should be noted that DMPC vesicles are not an entirely 
physiologically accurate model. Furthermore, they are somewhat
4unstable in the presence of apolipoproteins.^’^  They are used for 
several important reasons, however. First, the Tm of DMPC is only
23 9°C. Since the rate of degradation of particles is fastest at the 
gel-liquid crystalline transition temperature due to the increased 
permeability of the matrix , this temperature, near room temperature is 
very efficient to work with. Secondly, since only one type of lipid is 
present in DMPC vesicles, any change in the kinetics of reaction must 
have occured due to the addition of the alternate lipid. A number of 
different concentrations of the additional lipid were studied to analyze 
what trends were being generated.
»
5EXPERIMENTAL ANALYSIS
I. Materials--
The phospholipids used in both series of experiments, 
egg-Phosphatidyl Choline (egg-PC), DMPC, DMPE, DPPE, and DPPS, were 
purchased from the Sigma Chemical Co. in the L-configuration at i98% 
purity. The cholesterol, as well as the long chain fatty acids, myristic acid 
(Cj4). and palmitic acid (Cj^) were also purchased from Sigma Chemical
Co.. The ‘^C-labelled cholesterol was obtained from New England 
Nuclear Co.. The Spectropore *3 and #4 tubing was obtained from 
Spectrum Medical Industries.
Apolipoprotein A-1 and the mixture of apolipoprotein Cs were 
prepared via the Jonas and Matz method , with an original reference to 
Edelstein et a / *3. Apo A-I and Apo Cs were stored, lyophilized, at 
-2Q°C. They were then resuspended in separate preparations in 3M 
guanidine hydrochloride (GuHG) and dialized individually against a 
standard salt buffer consisting of : 0 .0 1M Tris HC1, 0.15M NaCl, ImM 
NaN ,^ and 0.005% EDTA, at a pH of 8 .0 , and temperature of 4°C. The
sonications carried out in the first series of experiments were done on a 
Heat Systems Ultrasonic Sonicator. The 1 ^  cholesterol was counted on a 
Beckman LS-3801 Liquid Scintillation Counter. The bovine serum 
albumin (BSA) and ferritin used in column calibration were obtained 
from Sigma Chemical Co. The column used in separating complexes was
*
6packed with BioGel Agarose A-5m beads purchased from BioRad 
Laboratories. The reagents used in the Lowry and Chen assays1 7 *®'^0 
were obtained from suitable suppliers and were of reagent grade. The 
absorbance at 280nm of the samples was measured on a Beckman Model 
35 Spectrophotometer. Standard equipment for both Gradient Gel 
Electrophoresis and SDS Polyacrylamide Gel Electrophoresis were used 
for these analyses. In the second series of experiments, the decrease in 
light scattering intensity of the MLV's after the addition of Apo A-1 was 
measured on a Perkin-Elmer MPF-3 Fluorescence Spectrophotometer.
II. Methods--
A. Preparation- The vesicles in the first series of experiments were 
formed by using an ultrasonication method similar to that pioneered by 
Huang® with an original reference to Saunders*^. A series of five 
mixtures of egg-phosphatidyl choline (egg-PC) and cholesterol were made 
so that the final egg-PC concentration would be 8 mg/ml and the 
egg-PC/cholesterol molar ratio would be 100/ 1. Into each mixture of 
lipid, approximately 2.0 x 10-^  cpm's of 14C-cholesterol were added. 
These lipids were mixed in a scintillation vial in a solution of (2:1) 
CHCh:MeOH and were dried down completely under pure nitrogen.
Standard salt buffer was then added and the mixture vortexed for three 
minutes, until all traces of iipid had been removed from the sides of the
vial. This left a dispersion of cloudy, milky-white Multi-Lamellar 
Vesicles I ML Vs).
This dispersion was then ultrasonicated under nitrogen at setting 6 
for 3 minute bursts with a minute break between each burst. This 
procedure was continued for 20 30 minutes until the dispersion cleared 
and took on the pale blue color of suspended titanium. The dispersion 
was then centrifuged in a Beckman Model J2IB Centrifuge at 15,000 rpms 
for one hour at 5°C. The supernatant was removed from the titanium 
pellet and stored at 4°C.
Prior to use in these experiments, separate solutions of 
apoiipoproteins were made from lyophilized Apo A-! and a mixture of 
Apo-C's. These apoiipoproteins were resuspended in 3M GuHCI and 
dialyzed extensively in a standard salt buffer. The concentrations of 
these proteins were checked by a modified Lowry assay 1718  (for both 
apoiipoproteins separately) and by a measurement of A2gQ ( for Apo A-l.
using an extinction coefficient of 11.5 cm^/gm  ^ )^.
The apoiipoproteins were then incubated for three hours with the 
lipid vesicles. Molar ratios of 100:1 lipid : protein were used, with 2mg 
of Apo A I being the amount from which lipid concentration was 
calculated. In cases where both Apo A-l and the miiture of Apo Cs 
were added to the same reaction, equal 2mg amounts of each were added.
Five different solutions were prepared. In tube !, a control, only Apo 
C s were added. In tube 2, another control, only Apo A-1 was added. In 
tube 3, both Apo A-1 and Apo C's were added simultaneously. In tube 4, 
Apo A-l was first added and the tube incubated for three hours; then
8Apo C's were added and the tube incubated again for three hours. Tube 5 
was treated similarly, only Apo C's were added and incubated prior to the 
subsequent addition of Apo A-1 and second incubation. All incubations 
were carried out at 37°C.
These five samples were then individually run down a BioGel A-5m 
column (2 x 60 cm), and a total of eighty 2ml fractions were collected
from each. For each fraction, both the A2gp and counts of , 4C-
cholesterol were measured and several fractions were pooled around 
points of absorbance or cpm maxima. (See figures 1- 5).
Since the main focus of the second series of experiments was the 
kinetics of protein:lipid interaction rather than the product formation, a 
different method of preparation was necessary. This method of 
preparation was begun similarly to that used in the first series, but the 
Multi-Lamellar Vesicles were not subsequently ultrasonicated. DMPC was 
used in this experiment rather than egg-PC for reasons noted above, and 
was mixed with a single additional lipid. The amount of this additional 
lipid was varied between 2 - 10%, and several lipids were introduced into 
DMPC MLV s in this way. Apolipoprotein A-1 stock solutions were 
prepared as noted before.
B. Absorbance- For each pooled fraction, a measurement of absorbtion 
at 280nm was made. The various aromatic amino acid residues present 
in the apolipoproteins will absorb at this wavelength. As a result, only
9those fractions containing free or lipid-bound protein, as well as very 
large particles, should give a significant absorbtion. Further, a Lowry 
test, as modified by Markwell, was performed The results of
these two tests should agree,
C. Measurement of Radioactivity- An aliquot of each pooled fraction 
was mixed into liquid scintillation fluid and placed into a Beckman Liquid 
Scintillation Counter as noted above. Each escaping electron has the 
potential to excite a molecule of fluorophore in the scintillation fluid. 
When this molecule relaxes it emits a brief flash of light which may be 
picked up and counted. For each fraction, a measurement of cpm's 
(counts per minute) of *^C-cholesterol was made. Only those fractions 
containing lipid should give significant counts.
D. Phosphate Analysis- Each pooled fraction was analyzed by the 
Chen et a l. ^  assay for organic phosphate. A standard curve for each 
day of measurement was set up by using inorganic phosphate standards. 
From this data, the fractions containing phospholipids may be identified 
and the phospholipid concentration calculated.
10
E. Column Calibration Samples of BSA, ferritin, and phospholipid 
complexes of a known size were run through the BioGel A-5m column. 
From the positions at which they elute (as measured by A2$o for the
proteins and cpm s for the complexes), an idea of the column s separating 
ability can be learned. This will give a rough estimate of the size of the 
sample complexes eluted during the experimental runs.
F. Gradient Gel Electrophoresis- For each of the pooled fractions a 
sample was run through a 4-30% gradient gel. These gels were then 
analyzed on an LKB Bromma Ultroscan Laser Densitometer. A cocktail 
mixture of standards containing albumin, lactate dehyrogenasc, catalase, 
ferritin, and thyroglobin was placed in two lanes on each gel. This 
method of analysis allows a great deal of sensitivity in measuring the size 
of major species present in each pooled fraction. It should be noted, 
however, that only a comparitively rough estimate may be made of any 
species larger than thyroglobin, the largest standard.
G. Sodium Deodecyl Sulfate- Polyacrylamide Gel Electrophoresis- The 
sodium deodecyl sulfate present in this gel acts as a detergent, breaking 
up the lipid complexes and freeing bound apolipoprotein. Each pooled 
fraction was run through a highly cross-linked ( 10%) gel against a 
number of small protein standards. This type of analysis allows a 
differentiation between vesicles containing bound Apo A-1 and bound
11
Apo C s. This will allow an insight into what is occuring in the mixed 
Apolipoprotein systems.
G. Fluorescence Analysis- In the second series of experiments, a 
dispersion of multi-lamellar vesicles was formed from DMPC and 
additional incorporated lipid as noted above. Each of the samples of 
MLV's was incubated at a specific temperature in a Perkin- Elmer 
Fluorescence Spectrophotometer. The large heterogeneous multi-lamellar 
vesicles scatter incident light easily. The scattered light can be read at 
90° to the incident light using a fluorescence spectrophotometer. 
Discoidal particles about 100 angstroms in diameter, on the other hand, 
scatter much less light. When Apolipoprotein A-I is introduced to the 
MLV system, it has been shown by Pownall et and others 1 
that the Apo A-I spontaneously breaks down the multi-lamellar vesicles 
into small, discoidal particles similar to nascent HDL. This breakdown has 
been studied by Pownall using a spectrophotometer. In this analysis the 
breakdown will be kinetically studied over time by observing the 
decrease in light scattering by the MLV dispersion after the inclusion of 
Apo A-I. The fluorescence spectrophotometer was set to both excite and 
detect scattered light at 350nm. No filter was used in this analysis. Both 
the excitation window and the emission window were set equally 
between two and three nanometers, in order to obtain an initial light 
scattering intensity of between 90 and 93 fluorescence units. After 
complete temperature equilibration of the dispersion, Apo A I was added
12
and mixed by inversion, and the decrease in light scattering measured as 
a function of time. It should be noted that a control reaction mixture 
containing no Apo A I was also analyzed to test for settling of the MLV 
dispersion.
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RESULTS
A. Gel Filtration Chromatograpy- In the first series of experiments, 
the reaction mixtures were run through a column of BioGel A-5 m in order 
to separate the product particles. The results have been summed up in 
Figures 1-5. Gel Filtration Chromatography is an important analytical tool 
used to separate various molecules based upon their molecular size. The 
column in this experiment was filled with a number of beads made of 
Agarose, an inert substance. Large macromolecules are able to flow 
around these beads and elute in an earlier fraction. Apolipoproteins in 
their unbound state are smaller than the apolipoprotein: lipid complexes 
and, thus, are eluted in a later position. The relative sizes of these 
protein-lipid complexes can also be indicated by their position of elution. 
This data has been presented in Section D.
B. Protein Measurement and CPM Data- In the first series of 
experiments, both the absorbance at 280 nm and the counts of 
*^C-cholesterol were measured for each pooled fraction. This data has 
been summed up in Table 1. It was noted that in one of the pooled 
fractions (D4) the A230 was extremely high while the number of counts
was virtually at background level. Other fractions (A 1. C3. C4, E3) show 
similar profiles. It was inferred from this data and from the position of
Melution of these fractions that the majority of this fraction, if not the 
entirety, in fraction D4, consisted of unbound protein. The Lowry test 
proved somewhat inconclusive due to low protein amounts, however 
there did exist cases where a measureable amount of protein was 
present. These conformed with the pooled fractions containing high 
absorbance and low counts.
C. Phosphate Analysis- The results of these analyses have been 
recorded in Table 2. As can be seen, the pooled fractions which contained 
a high level of ^C-cholesterol also contained a higher level of phosphate. 
This is to be expected since the phosphate is in the fraction that 
originates from the phospholipid bilayer of the complexes. This is where 
the cholesterol should also be incorporated.
D. Column Calibration-- A minor problem in resolution between the 
standards somewhat marred the effectiveness of this analysis. As a 
result of the standards eluting in fractions of such close proximity 
(ferritin- #56, lipid complexes- *58, and BSA- *60), an accurate standard 
curve could not be drawn. This was believed to have resulted from 
packing changes in the column by the time this analysis was performed. 
It should be noted that the unbound proteins eluted in a later fraction 
than that occupied by the suspected apolipoprotein lipid complexes. It 
was also of interest that the pooled fractions containing the suspected
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complexes eluted from the column in a range from two to twenty 
fractions earlier than the largest of the protein standards. This would 
seem to indicate a heterogeneous collection of complexes, ranging in size 
from slightly larger than ferritin (79 angstroms in diameter) to 
significantly larger than ferritin. The exact size of the complexes can not 
he calculated due to the lack of an accurate standard curve.
E. Gradient Gel Electrophoresis- By utilizing the method of gradient 
gel electrophoresis, it is possible to calculate fairly accurately the size of 
the complexes. The stain used in this analysis stains for proteins either in 
the lipid-bound or unbound state. Due to the length of time that the 
samples were electrophoresed (24 hours), however, any unbound Apo 
A-1 or Apo C's are able to pass completely through the gel. Only those 
proteins which are bound in complex form will be sufficiently retarded to 
show up on the gels. By comparing the positions of the complexes on the 
gel, as measured by the laser densitomiter, to those of the standards, the 
size of the complexes may be calculated. This information can be seen in 
Table 4. It was noted, however, that the range of sizes of the complexes 
went from a diameter of approximately 67 angstroms to greater than 250 
angstroms. (It should be remembered that there are complications 
associated with the calculation of sizes in the upper regions of this gel.) 
This is interesting, since it agrees roughly with the results collected from 
the column calibration. Also a point of major interest was that the 
smaller sized complexes (<100 angstroms in diameter) were only formed
! 6
when both Apo A-1 and Apo Cs were present. It did not seem to make 
much of a difference in which order the apolipoproteins were added, only 
the presence of both in the reaction.
F. Sodium Deodecyl Sulfate- Polyacrylamide Gel Electrophoresis 
Any Apo Cs which might be present would be travelling with the dye 
front and would be difficult to see. Furthermore, since a mixture of 
different Apo C's was used, this band would be diluted and spread out, 
and thus, also difficult to locate. As expected, this proved to be the case. 
No definite bands can be made out corresponding to the mixture of Apo 
C's. Bands corresponding to Apo A-l are present, however. The fractions 
which produced a band corresponding to Apo A-1 are : B2 (faint), C3 
(strong), C4 (faint), D3 (strong), and E3 (very faint).
G. Kinetic Study of Light Scattering Decrease- The results of this 
analysis have been summed up in Tables 4-9. It was noted that the 
addition of between 2-10 % of certain lipids (palmitic acid, myristic acid. 
DMPE, and DPPE) had a negative effect upon the rate of MLV degradation 
corresponding to the level of added lipid as compared to a system 
without such added lipid. The addition of low level amounts of 
cholesterol seemed to have a positive effect upon the rate*\ however,
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increasing the amount of cholesterol past the 6 molar % point had a 
negative effect. As shown in this study as wc. -s in similar studies done 
by Epand et al. 11. the addition of DPPS to a similar system had a positive 
effect upon the rate of MLV degradation. It was noted in this study that 
the rate of degradation is not greatly dependent upon the temperature 
until the Tm is reached (see Table 6 ). At this temperature there is a large
increase in rate (see Table 10). Similar results have been found by 
Pownall etoJ. .
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DISCUSSION
In the first series of experiments, it appeared as if the addition of 
both Apo A-I and the mixture of Apo C's were necessary for the 
formation of smaller size complexes ('100 angstroms). It did not appear 
important which of the two apolipoproteins was added first. In the two 
control experiments, where only one of the two types of apolipoproteins 
was added, a group of large particles were formed in the range from 250 
300 angstroms in radius. Moreover, the cpm peak for Trial A was 
narrower than that for any other trial. It would seem that the addition of 
Apo C's alone gives a large, but more homogeneous population of 
particles. Trial B seems to indicate that Apo A I is capable of 
spontaneously forming a population of large heterogeneous particles 
containing differing amounts of lipids and protein as has been shown 
before**.
In each of the three experimental trials (see Figures 3-5). a shoulder 
area appears in the cpm data in the range from fraction **50 to **54. This 
shoulder is absent from the controls. This is an indication that smaller 
sized complexes are being formed. This conclusion is borne out by the 
gradient gel data. In all but one of these shoulder region fractions, (C2), 
all the complexes are under 100 angstroms in diameter. In pooled 
fraction C2, two distinct species of particle are evident. This could have 
been caused by the range of fractions which were chosen.
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SDS-Polyacrylamide analysis of the four pooled fractions which gave 
smaller sized complexes indicates that Apo A-1 is definitely present in at 
least three of these fractions. It seems entirely plausible that at least a 
portion of the Apo A-l present is bound to lipid complexes. It has been 
shown by Jonas and others '6.22,23) that small complex discs contain two 
Apo A-I s whereas larger discs contain three Apo A-l's. It can not be 
said for certain that the larger particles formed in this study are large 
discs of this type. This is due to the fact that it is difficult to distinguish 
between discoidal micelles and spherical vesicles.
From the data obtained, it appears as if there is some sort of 
protein-protein interaction between the Apo A-1 and the Apo C's. The 
exact nature of this interaction can only be hypothesized at this point. It 
is possible that one of the apolipoproteins has a sort of catalytic effect on 
the system. One possible mechanism is that, for a time, both 
apolipoproteins may be attached to the same complex. This dual binding 
may somehow induce smaller particles to be formed. A second possible 
mechanism is that one of the apolipoproteins may bind to the lipid 
dispersion first, while the second apolipoprotein binds slower, but more 
preferentially to the large complexes which have formed. When this 
second apolipoprotein binds, it binds to a smaller amount of lipid bilayer. 
This means that the lipid bilayer is more highly curved, and thus, more 
likely to exhibit defects in the bilayer lattice. Since it did not matter 
which of the apolipoproteins was added first, it appears as if three hours 
of incubation may be enough to allow the system to completely 
equilibrate. Further experimentation with systems incubated for shorter
20
lengths of time may allow a distinction to be made or suggest a more 
concrete mechanism.
The second series of experiments gave some interesting results. In 
Henry J. Pownall s opinion9, the kinetics of the incorporation of Apo A-l 
into lipid vesicles is controlled less by any changes in the stucture of Apo 
A-I than it is by the "permeability ’ of the lipid bilayer. This is due to the 
fact that the protein:lipid bilayer interaction appears to be hydrophobic 
in nature. In the bilayer, the polar heads are ideally spaced a certain 
distance apart. Each phospholipid is in constant movement, however, and 
when enough space is present, Apo A-I is able to find a place to bind. 
This is why bilayers at a temperature equal to the Tffl react mor. quickly
with Apo A-I. Lattice defects are more numerous m the vicinity of a 
coexisting gel-liquid crystalline state. The liquid crystalline state is much 
more permeable than the gel state, but it appears that when the system 
is energetic enough (ie. when the experimental temperature is much 
greater than the Tm) the Apo A-I can not act quickly enough to attack
the lattice defect.
This idea of permeability may also give an explanation for the effects 
of incorporated lipids on the kinetics of bilayer breakdown. When 
thinking of a phospholipid it is easy to picture a cylinder where the 
hydrophobic effect exerted by the fatty acyl chains is compensated by 
the hydrophilic effect of the large polar head group. Fatty acids, however, 
have a large hydrophilic head, relative to one fatty acyl chain, Thus, 
fatty acids may be pictured as a cone. Phosphatidyl ethanolamine is the
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opposite. It has a small polar head group with a strongly hydrophobic 
end formed by two fatty acyl chains. Its appearance may be pictured as 
an inverted cone. Somehow, these two molecules with their opposite 
shapes, seem to cause the same effect, a stiffening" of the membrane, 
w’hich reduces membrane permeability. It is easy to imagine the 
inver’-id cone shape of the phophatidyl ethanolamine allowing the polar 
head groups to move closer together in that region due to polar head 
group interaction. It is harder to picture what physical effect the fatty 
acids might create that would "stiffen" the bilayer.
Cholesterol has been shown in the past to increase permeability when 
introduced in low concentration . It is supposed that the small amount of 
cholesterol provides the defect sought for by the Apo A-I. In higher 
concentrations, the cholesterol stays between the phospholipids and 
prevents the free movement of the fatty acyl chains. This hydrophobic 
bonding "stiffens the bi-layer, thus making it more crystalline-like. 
According to Epands hypothesis11, anionic phospholipids act by 
spreading the Tm of a phospholipid complex so that it occurs over a much
broader range. Thus, with increasing amounts of DPPS, the bi-layer acts 
more like it is at the critical transition state, where it is much more 
permeable to Apo A-l. Epand also suggests that the negative charge 
present at the polar head groups may make the polar head groups spread 
apart due to electrostatic repulsion. This, however, appears to be 
somewhat contraindicated by the results of the kinetic studies of palmitic 
and myristic acid effects in this study.
In conclusion, it appears as if several of the factors examined in this
22
study may have an effect upon HDL production in vivo. Apo C's appear 
to, in some way, facilitate the formation of smaller size particles in vitro. 
It is possible that they may have a similar function in the body. Certain 
lipids present within the body have an effect upon the rate of breakdown 
of large lipid bi-layers in vitro It seems possible that a similar effect 
may occur within the body and adjust the in vivo rate of HDL formation.
■^**7
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LIST OP ABBREVIATIONS
VLDL Very low density  lipoproteins
LDL Low density  lipoproteins
HDL High density  lipoproteins
LCAT Lecithin cholesterol acyl transferase
Apo A-I Apolipoprotein A-I
ApoC's A poiipoprotein C's
DMPC Dim yristoyl phosphatidyl choline
®i§- PC Egg- phosphatidyl choline
DMPB Dim yristoyl phosphatidyl ethanolam ine
DPPB Dipalmitoyl phosphatidyl ethanolam ine
DPPS Dipalmltoyl phosphatidyl serine
MLV M ulti-lam ellar vesicle
GuRQ Guanidine Hydrochloride
BSA Bovine serum  album in
SDS Sodium deodecyl sulfate
PF Pooled fraction
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Table 1.
Abaorbaoce and Count# of Eluted Pooled Fraction#
(PF)
S an p le
--------fi&AI-----
771.5 0.033
A2 1203.0 0.06*
A3 01)79
E l 313.3 0.040
B2 *77.3 0.030
Cl 333.0 0.032
C2 1073.3 0.037
C3 237.3 0.1*3
C4 6 1 0 0.1*3
473.3 0 0 4 2
D2 *3011 0 0 3 3
D3 4 4 3 0 0.120
D4 3211
**311 0.070
K2 •  13.3 0 0 2 7
J 1 _____ ____2 tL fl____ __ H IM -
Table 2.
Phosphate concentration of pooled fractions
Sample Average phosphate
__i r i i -------concenirauon i  i u -j
6.13
—A2— 8.06
A3 1.97
.-Bl 2.69
B2______ 6.02
_________ 6.18
_C2________________ L 53__________
C3 4.08
C4 2.20
i l l 3.39
-D2 5.97
5.70
Bl 4.69
6.08
J B _______________ i i S __________
Table 3
Measurement of S ize o f P a rtic le  Contained in Pooled Fractions  
As C alculated by Gradient Gel Electrophoresis.
A1 >250
A2 >250_______
A 1 _______ No P a rtic le s  P resen t
BJ >250
B2 247 >250
Cl >250
C2 >250
C3
C4 >250
Dl >250 >250
D2 245.1 >250
03 92.fi ______
No P artic le*  P resen t
FI >250
_ £ 2 _________ _____ 2250________________ >250 -------------------------------
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Table 4
Kinetic Analysis of Rate of Degradation of MLV's Containing 
Palm itic Acid A fter 3 and 10 m inutes (n -2 )
T-21.3°C
% Palm itic A dd R alm io*1) Rio (min*1)
0 ... 10.3 4.7 _ .
2 10.3 5.2
4 6.7 5.6. —
6 4.0 LB _
.......... 8......... 1 J 1.15
_____ U L _ _______ 12______
Table 3
Kinetic Analysis of Rate of Degradation of MLV'i Containini 
M yriatic Acid A fter 3 and 10 m inutes (n -2 )
T-21.3^
t  MvriiUc Add__ __ Riimin'J______Rislmin'l—
12____________ IXLi___________ 41
2__________________1 0 _______________ U
.. . 4 ................. I
i n i -----------
I
6 42
B 22
_____ 112_________ _________2J2________ ________LZ______
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T itle  6
Kinetic Analysis of Rate of Degradation of MLV's Containing 
DPPB A fter 3 and 10 m inutes (n -2 )
T-21.5°C
%  DPPB_____________ R ilm in '1]_________ Rio Im in 'JL .
0 A il 3.0
______ 2__________________13_______ _______ 2,1
4________________ iL3________________I fL
f t _________________4J)________________ L f il
8 2.13 i i
_____ if!________ _________ m _______ 1.95___
Table 7
Kinetic Analysis of Rate of Degradation of MLV's Containing 
DMPE A fter 3 and 10 m inutes (n -2 )
T-21.5°C
» DMPE R a in in '1) Rio (min*1)
0 9.5 3 .8 _____
2 X X
4 1.55
6 2.15
8 ........................  2 .5_______ 2.15
_____ LQ__ __________________ 1 6 5 _____
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T ab les
Kinetic Analysis of Rate of D egradation of ML V s Containing 
DPPS A fter 3 and 10 m inutes (n -2 )
JL JPK
T-21,3^ C
RlfaifT1) Rl« fain*1)
____ Q 10.5 6.15
____ 2 g.0 5.1
____ i - 0.7 5.3
____ 6 14.7 6.9
_____ s 16i 8.15
____10 ___ 7J
Table 9
Kinetic A nalysis of Rate of Degradation <* MLV s Containing 
Cholesterol A fter 3 and 10 m inutes (n -2 )T-21.J°C
Rs (ain'1) ___ Rielaiif'L-
____ 0________ 9.15 3.6
___ 10-3
4 --------------------------- 1--------------------------- 1 2
_ 1 t i l 5 05
- _______ ________1 2 2 ____
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Table 10
Tem perature Effects on Average Rate of MLV Degradation 
T em perature K._____ Ra (min=il
21.3 9.4
6.63
_____ 23.0 *7
2 1 3 ______________ I d
212________ 12.
*_ 24.1
----  *1
14.0
" ____ 23.1 I3a3_____
* Note: Ri -3 3  m in '1 and reaction la approxim ately 73% com plete after 1tain
“ Sim ilar to  above.
